K. Itoh

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
K Itoh, Kunihiko Itoh
Publication record
132 papers · 2,630 citations · H-index 28

PAPERS

Chromosome-Specific Quantification of TERRA in Peripheral Blood and Its Association with Depressive Symptoms
20260 citationsauthor #6
Development of a predictive model for neutropenia risk in Japanese breast cancer patients treated with doxorubicin and cyclophosphamide
20250 citationsauthor #7
Influence of Organic Cation Transporter 3 (SLC22A3) Genetic Polymorphisms on Antidepressant Maintenance Doses in Japanese Patients with Depression
20250 citationsauthor #5
Pharmacogenomic study of gemcitabine on the safety and efficacy in patients with metastatic pancreatic cancer (GENESECT study): Analysis of a subpopulation.
20240 citationsauthor #19
Pharmacogenomic study of gemcitabine efficacy in patients with metastatic pancreatic cancer: A multicenter, prospective, observational cohort study (GENESECT study)
20243 citationsauthor #22
Gene Polymorphisms of NLRP3 Associated With Plasma Levels of 4β‐Hydroxycholesterol, an Endogenous Marker of CYP3A Activity, in Patients With Asthma
20242 citationsauthor #6
Changes in estimated glomerular filtration rate in patients administered proton pump inhibitors: a single-center cohort study
20242 citationsauthor #6
A multicenter phase II trial of the triplet antiemetic therapy with palonosetron, aprepitant, and olanzapine for a cisplatin-containing regimen. - PATROL-I-
20231 citationsauthor #17
Chemotherapy-induced neutropenia as a prognostic factor in patients with extensive-stage small cell lung cancer
20235 citationsauthor #19
Relevance of pharmacogenetic polymorphisms with response to docetaxel, cisplatin, and 5-fluorouracil chemotherapy in esophageal cancer
20210 citationsauthor #9
Benralizumab restores gene and microRNA expression involved in steroid sensitivity in severe asthma
20217 citationsauthor #7
Impact of CYP2D6 activity and cachexia progression on enantiomeric alteration of plasma tramadol and its demethylated metabolites and their relationships with central nervous system symptoms in head and neck cancer patients
20203 citationsauthor #6
Analysis of pharmacogenomic factors for chemotherapy-induced nausea and vomiting in patients with breast cancer receiving doxorubicin and cyclophosphamide chemotherapy
202013 citationsauthor #11
Benralizumab restored expression of key molecules involved in steroid-resistance in patients with severe asthma
20200 citationsauthor #10
Combined assessment of serum eosinophil-derived neurotoxin and YKL-40 may identify Asthma-COPD overlap.
20208 citationsauthor #7
A Reversed-Phase Mode LC-MS/MS Method Using a Polysaccharide Chiral Selector for Simultaneous Quantitation of Each Enantiomer of Tramadol and its Metabolites in Human Plasma and Evaluation of CYP-Mediated Stereoselective Demethylation.
20203 citationsauthor #5
ABCB1 and ABCC2 genetic polymorphism as risk factors for neutropenia in esophageal cancer patients treated with docetaxel, cisplatin, and 5-fluorouracil chemotherapy
202012 citationsauthor #10
Circulating microRNA‐15b‐5p as a biomarker for asthma‐COPD overlap
202033 citationsauthor #7
Anti-Idiotype DNA Aptamer Affinity Purification–High-Temperature Reversed-Phase Liquid Chromatography: A Simple, Accurate, and Selective Bioanalysis of Bevacizumab
20199 citationsauthor #9
Forced oscillation technique may identify severe asthma.
20197 citationsauthor #7
Effect of CYP4F2, VKORC1, and CYP2C9 in Influencing Coumarin Dose: A Single‐Patient Data Meta‐Analysis in More Than 15,000 Individuals
201930 citationsauthor #30
[BIOMARKERS FOR PREDICTING FUTURE EXACERBATIONS IN ADULT PATIENTS WITH ASTHMA].
20190 citationsauthor #3
Impact of gene expression associated with glucocorticoid-induced transcript 1 (GLCCI1) on severe asthma and future exacerbation.
201915 citationsauthor #7
Comparison of the association between circulating vitamin D3 levels and clinical outcomes in patients with asthma and chronic obstructive pulmonary disease: a prospective observational study.
20193 citationsauthor #5
CYP2C9, VKORC1, and CYP4F2 polymorphisms and pediatric warfarin maintenance dose: a systematic review and meta-analysis
201911 citationsauthor #18
Combined Assessment of Serum Periostin and YKL-40 May Identify Asthma-COPD Overlap.
201959 citationsauthor #8
Forced oscillation technique may identify asthma-COPD overlap.
20197 citationsauthor #7
Risk factors associated with chemotherapy-induced nausea and vomiting in the triplet antiemetic regimen including palonosetron or granisetron for cisplatin-based chemotherapy: analysis of a randomized, double-blind controlled trial
201828 citationsauthor #11
Validation of a Nomogram for Achieving Target Trough Concentration of Vancomycin: Accuracy in Patients With Augmented Renal Function
201816 citationsauthor #6
Association between (CCTTT)n repeat polymorphism in NOS2 promoter and asthma exacerbations.
201813 citationsauthor #5
Human recombinant Fab fragment from combinatorial libraries of a B-cell lymphoma patient recognizes core protein of chondroitin sulphate proteoglycan 4
20182 citationsauthor #7
Chemotherapy-induced neutropenia as a prognostic factor in patients with metastatic pancreatic cancer treated with gemcitabine
201720 citationsauthor #11
Comprehensive study of risk factors for chemotherapy-induced nausea and vomiting in cancer patients receiving cisplatin-based chemotherapy: A TRIPLE pharmacogenomics study.
20171 citationsauthor #15
Comparative Investigation of the Antiemetic Efficacy of Aprepitant Containing Antiemetic Regimen in Breast Cancer Patients Receiving Doxorubicin and Cyclophosphamide Combination Chemotherapy
20170 citationsauthor #12
O2-18-2Risk factors of CINV induced by CDDP in antiemetic triplet regimen including palonosetron or granisetron: TRIPLE study
20170 citationsauthor #6
Association between pentanucleotide repeat polymorphism in NOS2 promoter and asthma exacerbations
20170 citationsauthor #6
Genetic risk factors for chemotherapy-induced nausea and vomiting in patients with cancer receiving cisplatin-based chemotherapy
20177 citationsauthor #15
A clustering approach to identify and characterize the asthma and chronic obstructive pulmonary disease overlap phenotype
201730 citationsauthor #13
Synthesis of Chemical-Biology Tools Enabling in vivo Imaging and Analysis of Epigallocatechin Gallate
20160 citationsauthor #5
Influence of Genetic Polymorphisms and Concomitant Anxiolytic Doses on Antidepressant Maintenance Doses in Japanese Patients with Depression.
20164 citationsauthor #11
Risk factors for hypernatremia in patients with short- and long-term tolvaptan treatment
201624 citationsauthor #9
Influence of ABCB1 and ABCG2 polymorphisms on the antiemetic efficacy in patients with cancer receiving cisplatin-based chemotherapy: a TRIPLE pharmacogenomics study
201620 citationsauthor #15
Augmented Renal Clearance in Pediatric Patients With Febrile Neutropenia Associated With Vancomycin Clearance
201662 citationsauthor #7
Bioanalysis of bevacizumab and infliximab by high-temperature reversed-phase liquid chromatography with fluorescence detection after immunoaffinity magnetic purification.
201619 citationsauthor #12
Augmented Renal Clearance in Patients With Febrile Neutropenia is Associated With Increased Risk for Subtherapeutic Concentrations of Vancomycin
201670 citationsauthor #8
Factors that influence the pharmacokinetics of lamotrigine in Japanese patients with epilepsy
20162 citationsauthor #11
Drug-related genetic polymorphisms affecting severe chemotherapy-induced neutropenia in breast cancer patients
201623 citationsauthor #14
Risk factors for hypernatremia in patients with short- and long-term tolvaptan treatment
20160 citationsauthor #9
Factors that influence the pharmacokinetics of lamotrigine in Japanese patients with epilepsy
201616 citationsauthor #11
Depth of field extension technology for two-dimensional code reader
20161 citationsauthor #3
1580 Influence of ABCB1 and ABCG2 polymorphisms on the antiemetic efficacy of a triple antiemetic combination in cancer patients receiving cisplatin-based chemotherapy: TRIPLE Pharmacogenomics Study
20150 citationsauthor #13
Immuno-Northern Blotting: Detection of RNA Modifications by Using Antibodies against Modified Nucleosides
201581 citationsauthor #4
Correction.
20150 citationsauthor #1
Reduced folate carrier 1 gene expression levels are correlated with methotrexate efficacy in Japanese patients with rheumatoid arthritis.
20159 citationsauthor #11
Plasma vitamin K concentrations depend on CYP4F2 polymorphism and influence on anticoagulation in Japanese patients with warfarin therapy.
201517 citationsauthor #12
Influence of glutamine synthetase gene polymorphisms on the development of hyperammonemia during valproic acid-based therapy.
201510 citationsauthor #10
Relationship between ABCB1 gene polymorphisms and severe neutropenia in patients with breast cancer treated with doxorubicin/cyclophosphamide chemotherapy.
201523 citationsauthor #13
P1-26-1ASSOCIATION OF ABC POLYMORPHISM WITH ANTIEMETIC EFFICACY IN CANCER PATIENTS TREATED WITH HIGHLY EMETOGENIC CHEMOTHERAPY
20140 citationsauthor #10
Identification of anti-CD98 antibody mimotopes for inducing antibodies with antitumor activity by mimotope immunization
20147 citationsauthor #9
Influence of Uridine Diphosphate Glucuronosyltransferase 2B7 −161C>T Polymorphism on the Concentration of Valproic Acid in Pediatric Epilepsy Patients
201437 citationsauthor #12
Endothelin-1 receptors in rat tissues: characterization by bosentan, ambrisentan and CI-1020.
20145 citationsauthor #4
Bladder endothelin-1 receptor binding of bosentan and ambrisentan.
20141 citationsauthor #4
Prognostic Factors in Patients with Unresectable Pancreatic Cancer Treated with Gemcitabine: A Retrospective Analysis
20142 citationsauthor #10
Retrospective Analysis of Severe Neutropenia in Patients Receiving Concomitant Administration of Docetaxel and Clarithromycin
20149 citationsauthor #10
Conformational change in transfer RNA is an early indicator of acute cellular damage.
2014101 citationsauthor #35
Simultaneous microdetermination of bosentan, ambrisentan, sildenafil, and tadalafil in plasma using liquid chromatography/tandem mass spectrometry for pediatric patients with pulmonary arterial hypertension.
201436 citationsauthor #10
Contents Vol. 59, 2013
20140 citationsauthor #63
[111th Scientific Meeting of the Japanese Society of Internal Medicine: Symposium: 2. Perspective of treatment in the vascular lesion of various organs; 5) Biological aspect of chronic kidney disease and the new therapy].
20140 citationsauthor #3
Characterization of the carrier‐mediated transport of ketoprofen, a nonsteroidal anti‐inflammatory drug, in rabbit corneal epithelium cells
20136 citationsauthor #3
Influence of CYP4F2 polymorphisms and plasma vitamin K levels on warfarin sensitivity in Japanese pediatric patients.
201320 citationsauthor #8
A single nucleotide polymorphism of reduced folate carrier 1 predicts methotrexate efficacy in Japanese patients with rheumatoid arthritis.
201344 citationsauthor #13
Association of ABCB1 polymorphisms with the antiemetic efficacy of granisetron plus dexamethasone in breast cancer patients.
201325 citationsauthor #10
Influence on the Concomitant Drug in RA Patients Using Biological Medication
20130 citationsauthor #6
Polymorphisms of the UDP-glucuronosyl transferase 1A genes are associated with adverse events in cancer patients receiving irinotecan-based chemotherapy.
201337 citationsauthor #15
P1–098A RETROSPECTIVE ANALYSIS OF NEUTROPENIA IN PATIENTS RECEIVING CONCOMITANT ADMINISTRATION OF DOCETAXEL AND CLARITHROMYCIN
20130 citationsauthor #10
Risk factors for hyperammonemia in pediatric patients with epilepsy
201349 citationsauthor #7
Risk factors for hyperammonemia associated with valproic acid therapy in adult epilepsy patients.
201247 citationsauthor #6
An artifact derived from a pseudogene led to the discovery of microRNA binding site polymorphism in the 3'-untranslated region of the human dihydrofolate reductase gene.
20126 citationsauthor #11
Genotype distributions and allele frequencies of possible major depressive disorder-associated single nucleotide polymorphisms, cyclic adenosine monophosphate response element binding protein 1 rs4675690 and Piccolo rs2522833, in a Japanese population.
20123 citationsauthor #6
[Merits of university-cooperation for preparing the contents of clinical case discussions].
20121 citationsauthor #1
Concise synthesis of catechin probes enabling analysis and imaging of EGCg.
201123 citationsauthor #12
Dihydrofolate reductase gene intronic 19-bp deletion polymorphisms in a Japanese population.
201016 citationsauthor #11
Generation of a recombinant single-chain variable fragment (scFv) targeting 5-methyl-2'-deoxycytidine.
20106 citationsauthor #5
Generation of Fab Fragment-Like Molecular Recognition Proteins against Staphylococcal Enterotoxin B by Phage Display Technology
201022 citationsauthor #2
Generation of AcGFP fusion with single-chain Fv selected from a phage display library constructed from mice hyperimmunized against 5-methyl 2'-deoxycytidine.
201011 citationsauthor #6
Prediction of antidepressant response to milnacipran by norepinephrine transporter gene polymorphisms.
201082 citationsauthor #9
Antibody epitope peptides as potential inducers of IgG antibodies against CD98 oncoprotein
200912 citationsauthor #1
Effect of VKORC1-1639 G>A polymorphism, body weight, age, and serum albumin alterations on warfarin response in Japanese patients.
200976 citationsauthor #11
Genetic polymorphisms in folate pathway enzymes as a possible marker for predicting the outcome of methotrexate therapy in Japanese patients with rheumatoid arthritis
200960 citationsauthor #6
Plasma total homocysteine level and methylenetetrahydrofolate reductase 677C>T genetic polymorphism in Japanese patients with rheumatoid arthritis
200923 citationsauthor #8
Literature Search on the Interaction Between Warfarin and Vitamin K
20091 citationsauthor #9
[Folic acid reduces the risk of neural tube defects: awareness and folate intake among pregnant women in 2006].
20085 citationsauthor #22
Influence of the tyrosine hydroxylase val81met polymorphism and catechol‐O‐methyltransferase val158met polymorphism on the antidepressant effect of milnacipran
200861 citationsauthor #8
Application of fluorescence polarization immunoassay for determination of methotrexate-polyglutamates in rheumatoid arthritis patients.
200822 citationsauthor #6
Identification of cell proliferation‐associated epitope on CD98 oncoprotein using phage display random peptide library
200712 citationsauthor #1
[Development of diagnostically and therapeutically useful human antibody medicines by phage display system].
20076 citationsauthor #1
Genetic polymorphism of C452T (T127I) in human gamma-glutamyl hydrolase in a Japanese population.
200710 citationsauthor #5
Genetic Polymorphism of C452T (T127I) in Humanγ-Glutamyl Hydrolase in a Japanese Population(Biopharmacy)
200714 citationsauthor #5
The G196A polymorphism of the brain-derived neurotrophic factor gene and the antidepressant effect of milnacipran and fluvoxamine
200784 citationsauthor #7
Cloning and expression of two human recombinant monoclonal Fab fragments specific for EBV viral capsid antigen.
20077 citationsauthor #5

TIMELINE

1975 106 citations

1981 4 citations

1992 27 citations

1999 26 citations

2000 1 citations

2001 17 citations

2002 503 citations

2003 52 citations

2004 149 citations

2005 0 citations

2006 11 citations

2007 150 citations

2008 88 citations

2009 172 citations

2010 137 citations

2011 23 citations

2012 57 citations

2013 181 citations

2014 198 citations

2015 140 citations

2016 241 citations

2017 58 citations

2018 59 citations

2019 141 citations

2020 72 citations

2021 7 citations

2023 6 citations

2024 7 citations

2025 0 citations

2026 0 citations

K. Itoh

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT